World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
25660
World Ranking
17028
National Ranking
8541

Lois B. Travis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lois B. Travis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 277 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lois B. Travis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lois B. Travis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lois B. Travis is affiliated with the University of Rochester Medical Center in the United States. Their research primarily spans the field of Medicine, with a strong focus on Oncology, Surgery, Pulmonary and Respiratory Medicine, Sensory Systems, and Molecular Biology.

The scientist's work covers a range of topics, including:

  • Testicular diseases and treatments
  • Hearing, Cochlea, Tinnitus, Genetics
  • Cancer Treatment and Pharmacology
  • Cancer-related cognitive impairment studies
  • Hearing Loss and Rehabilitation
  • Ear and Head Tumors
  • Brain Metastases and Treatment

Lois B. Travis has contributed significantly to peer-reviewed journals, particularly the Journal of Clinical Oncology, where they have 18 publications. Other frequent publication venues include JNCI Cancer Spectrum, Cancer Medicine, Cancer Epidemiology Biomarkers & Prevention, and JNCI Journal of the National Cancer Institute.

Recent published papers from this scientist are:

  • "Young Adult Cancer Survivorship: Recommendations for Patient Follow-up, Exercise Therapy, and Research" (2020, JNCI Cancer Spectrum)
  • "Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy" (2023, Journal of Clinical Oncology)
  • "Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy" (2022, Cancer Medicine)
  • "Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship" (2023, Journal of Clinical Oncology)
  • "Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments" (2022, Ear and Hearing)

This researcher collaborates frequently with other scientists, including Chunkit Fung, Paul C. Dinh, Darren R. Feldman, Lawrence H. Einhorn, and David J. Vaughn.

Best Publications

  • Solid Cancers after Bone Marrow Transplantation

    Rochelle E. Curtis;Philip A. Rowlings;H. Joachim Deeg;Donna A. Shriner

  • Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

    Lois B. Travis;Sophie D. Fosså;Sara J. Schonfeld;Mary L. McMaster

  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

    Rochelle E. Curtis;Lois B. Travis;Philip A. Rowlings;Gérard Socié

  • Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

    Lois B. Travis;Deirdre A. Hill;Graça M. Dores;Mary Gospodarowicz

  • Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases.

    Jorge R. Toro;Lois B. Travis;Hongyu Julian Wu;Kangmin Zhu

  • Cancer Surveillance Series: Non-Hodgkin’s Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995

    Frank D. Groves;Martha S. Linet;Lois B. Travis;Susan S. Devesa

  • Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

    Graça M. Dores;Catherine Metayer;Rochelle E. Curtis;Charles F. Lynch

  • Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease

    Lois B. Travis;Mary Gospodarowicz;Rochelle E. Curtis;E. Aileen Clarke

  • Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

    Lois B. Travis;Rochelle E. Curtis;Joseph F. Fraumeni;John D. Boice

  • Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

    Lois B. Travis;Deirdre Hill;Graça M. Dores;Mary Gospodarowicz

  • Solid cancers after allogeneic hematopoietic cell transplantation

    J. Douglas Rizzo;Rochelle E. Curtis;Gérard Socié;Kathleen A. Sobocinski

  • Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

    Ola Landgren;Ethel S. Gilbert;J. Douglas Rizzo;Gérard Socié

  • Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group.

    R B Hayes;S N Yin;M Dosemeci;G L Li

  • Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's Lymphoma

    Lois B. Travis;Rochelle E. Curtis;Bengt Glimelius;Eric J. Holowaty

  • Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin’s Disease

    Flora E. van Leeuwen;Willem J. Klokman;Marilyn Stovall;Ellen C. Dahler

  • Risk of leukemia after platinum-based chemotherapy for ovarian cancer.

    Lois B. Travis;Eric J. Holowaty;Kjell Bergfeldt;Charles F. Lynch

  • Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

    David C. Hodgson;Ethel S. Gilbert;Graça M. Dores;Sara J. Schonfeld

  • New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia

    G Socié;R E Curtis;H J Deeg;K A Sobocinski

  • Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

    Anil K. Chaturvedi;Eric A. Engels;Ethel S. Gilbert;Bingshu E. Chen

  • Second Cancers Among Long-Term Survivors of Hodgkin’s Disease Diagnosed in Childhood and Adolescence

    Catherine Metayer;Charles F. Lynch;E. Aileen Clarke;Bengt Glimelius

Frequent Co-Authors

Hans H. Storm
Hans H. Storm Danish Cancer Society
Charles F. Lynch
Charles F. Lynch University of Iowa
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Eero Pukkala
Eero Pukkala Tampere University
Marilyn Stovall
Marilyn Stovall The University of Texas MD Anderson Cancer Center
John D. Boice
John D. Boice Vanderbilt University
Per Hall
Per Hall Karolinska Institute
Mary K. Gospodarowicz
Mary K. Gospodarowicz Princess Margaret Cancer Centre
Heikki Joensuu
Heikki Joensuu University of Helsinki
Bengt Glimelius
Bengt Glimelius Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't always mean following the traditional path. Today, there are a variety of cheap rn to bsn programs that make it more accessible for registered nurses to upgrade their qualifications and boost earning potential without breaking the bank.

For those with a non-nursing background who wish to transition into healthcare, entry level msn programs online offer an accelerated route. These flexible online degrees cater to career changers looking to make a meaningful impact in medicine quickly.

If you're concerned about admissions difficulty, some easy nursing programs to get into provide less competitive acceptance standards while still delivering quality education. This opens doors for more prospective students hoping to break into the healthcare sector.

Not all roles require years of clinical study. Administrative positions, like medical coding and billing, are in demand. You can find accredited medical coding and billing classes online with financial aid to help you start a new career quickly and affordably.

Best Scientists Citing Lois B. Travis

Trending Scientists

Recently Published Articles